drugset
drugset / Trial / NCT04343092

Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management

NCT04343092 ↗

Phase 1 Completed 16 enrolled University of Baghdad
NaSingle-groupOpen-labelTreatment

Summary

Comparing the effectiveness of Ivermectin( IVM) +Hydroxychloroquin + azithromycin (AZT) group to Hydroxychloroquin (HCQ) + azithromycin (AZT)

Timeline

Start
2020-04-18
Primary completion
2020-05-31
Completion
2020-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 0.2 mg/kg —

Indications

COVID-19